Biomarker Studies on Radiotherapy to Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|84|1|64-68

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.1, 2013-02, pp. : 64-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TPX2 as a novel prognostic biomarker for hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 8, 2015-08 ,pp. : 906-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multimodality Treatment with Radiotherapy for Huge Hepatocellular Carcinoma

By  

Oncology, Vol. 87, Iss. 1, 2014-11 ,pp. : 82-89

Karger

Access to resources Recommend Favorite

Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach

By              

International Journal of Molecular Medicine, Vol. 29, Iss. 5, 2012-01 ,pp. : 832-840

Spandidos Publications

Access to resources Recommend Favorite

Multimodality Treatment Involving Radiotherapy for Advanced Liver-Confined Hepatocellular Carcinoma

By  

Oncology, Vol. 87, Iss. 1, 2014-11 ,pp. : 90-98

Karger

Access to resources Recommend Favorite

Brain metastasis from hepatocellular carcinoma: The impact of radiotherapy on control of intracranial hemorrhage

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1071-1075

John Wiley & Sons Inc

Access to resources Recommend Favorite